We are live on ! Find out more
EFM

E Fund Management Portfolio holdings

AUM $4.46B
This Fund
S&P 500
This Quarter Est. Return
+6.51%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.95B
AUM Growth
+$137M
Cap. Flow
+$63.5M
Cap. Flow %
3.26%
Top 10 Hldgs %
62.7%
Holding
375
New
57
Increased
197
Reduced
86
Closed
22

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$12.1M
2
AAPL icon
Apple
AAPL
+$11.7M
3
NVDA icon
NVIDIA
NVDA
+$9.16M
4
AVGO icon
Broadcom
AVGO
+$6.03M
5
PDD icon
Pinduoduo
PDD
+$5.45M

Top Sells

Rank Stock Value
1
ASX icon
ASE Group
ASX
+$18.3M
2
SE icon
Sea Limited
SE
+$11.3M
3
TSM icon
TSMC
TSM
+$9.27M
4
ZTO icon
ZTO Express
ZTO
+$7.08M
5
NIO icon
NIO
NIO
+$4.53M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 37.74%
2 Technology 30.94%
3 Communication Services 8.5%
4 Healthcare 6.31%
5 Financials 5.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GS icon
301
Goldman Sachs
GS
$301B
$225K 0.01%
454
-30
-6% -$14.7K
PGR icon
302
Progressive
PGR
$127B
$225K 0.01%
+885
New +$206K
VERA icon
303
Vera Therapeutics
VERA
$2.44B
$224K 0.01%
5,073
-2,322
-31% -$88.1K
GEN icon
304
Gen Digital
GEN
$18.4B
$224K 0.01%
+8,170
New +$210K
TRMB icon
305
Trimble
TRMB
$14.3B
$224K 0.01%
+3,601
New +$201K
ARWR icon
306
Arrowhead Research
ARWR
$12B
$222K 0.01%
11,438
+2,538
+29% +$61.9K
ENPH icon
307
Enphase Energy
ENPH
$4.93B
$220K 0.01%
+1,949
New +$218K
DNLI icon
308
Denali Therapeutics
DNLI
$3.83B
$220K 0.01%
7,561
-1,639
-18% -$40.6K
ZBH icon
309
Zimmer Biomet
ZBH
$19.3B
$218K 0.01%
2,022
+105
+5% +$11.5K
AKAM icon
310
Akamai
AKAM
$15.4B
$218K 0.01%
+2,158
New +$210K
ALGN icon
311
Align Technology
ALGN
$11.2B
$217K 0.01%
+855
New +$202K
RYTM icon
312
Rhythm Pharmaceuticals
RYTM
$7.42B
$217K 0.01%
+4,149
New +$199K
STE icon
313
Steris
STE
$22.8B
$217K 0.01%
893
-46
-5% -$10.8K
WST icon
314
West Pharmaceutical
WST
$23.8B
$215K 0.01%
717
+83
+13% +$25.4K
CAH icon
315
Cardinal Health
CAH
$54.6B
$215K 0.01%
1,942
-112
-5% -$11.7K
MIRM icon
316
Mirum Pharmaceuticals
MIRM
$5.97B
$214K 0.01%
+5,491
New +$219K
WBD icon
317
Warner Bros
WBD
$72.1B
$213K 0.01%
25,869
+1,928
+8% +$15.1K
URI icon
318
United Rentals
URI
$64.5B
$212K 0.01%
+262
New +$188K
SNDX icon
319
Syndax Pharmaceuticals
SNDX
$1.74B
$212K 0.01%
11,020
+214
+2% +$4.42K
COO icon
320
Cooper Companies
COO
$13.9B
$211K 0.01%
+1,913
New +$186K
DGX icon
321
Quest Diagnostics
DGX
$26.8B
$211K 0.01%
+1,359
New +$203K
RVTY icon
322
Revvity
RVTY
$14.4B
$210K 0.01%
+1,645
New +$193K
TECH icon
323
Bio-Techne
TECH
$11.4B
$210K 0.01%
+2,628
New +$197K
LH icon
324
Labcorp
LH
$27.3B
$210K 0.01%
+939
New +$206K
HOLX
325
DELISTED
Hologic
HOLX
$208K 0.01%
2,558
-157
-6% -$12.6K
11 12
13
14 15

Similar funds

ACM
Advent Capital Management New York $4.46B AUM 0.73% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
MAM
Magellan Asset Management Sydney, Australia $4.47B AUM 4.2% 1-Year Est. Return
AP
Americana Partners Houston, Texas $4.44B AUM 29.45% 1-Year Est. Return
BP
BC Partners New York $4.43B AUM 49.12% 1-Year Est. Return
WSFS
Wilmington Savings Fund Society Wilmington, Delaware $4.48B AUM 24.77% 1-Year Est. Return
AOI
Auto-Owners Insurance Lansing, Michigan $4.43B AUM 30.05% 1-Year Est. Return
WA
WestEnd Advisors Charlotte, North Carolina $4.49B AUM 19.44% 1-Year Est. Return

E Fund Management's Q3 2024 Portfolio in Review

As of Q3 2024, E Fund Management held 375 positions worth $1.95B, up 7.6% from $1.81B the previous quarter. Its ten largest holdings account for 63% of the portfolio.

E Fund Management deployed $63.5M of net new capital in Q3 2024, opening 57 new positions and adding to 197 existing holdings. Its largest new stake was argenx: 5,800 shares worth $3.14M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 38% of assets, down from 40% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was TSMC, an estimated $9.27M trimmed.

  • E Fund Management's largest Q3 2024 buy was argenx: 5,800 shares worth $3.14M.
  • E Fund Management added most to Microsoft in Q3 2024, an estimated $12.1M increase.
  • E Fund Management's biggest Q3 2024 reduction was TSMC, cutting an estimated $9.27M.
  • E Fund Management fully exited ASE Group in Q3 2024, selling an estimated $18.3M.
  • E Fund Management's ten largest holdings make up 63% of its $1.95B portfolio in Q3 2024.
  • E Fund Management opened 57 new positions and closed 22 in Q3 2024.
  • E Fund Management's portfolio value rose 7.6% quarter-over-quarter to $1.95B.

Based on E Fund Management's 13F filing for Q3 2024, filed 13 Nov 2024.